Brief: Reneo Pharmaceuticals Reports Third Quarter Results

Onkure Therapeutics

08/11/2022 15:26

Nov 8 (Reuters) - Reneo Pharmaceuticals Inc  RPHM.O :
    * RENEO PHARMACEUTICALS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
    * QTRLY LOSS PER SHARE $0.53
    * COMPANY HAD ABOUT $116 MILLION IN CASH, CASH EQUIVALENTS
AND
SHORT-TERM INVESTMENTS AS OF SEPTEMBER 30, 2022
    * RENEO PHARMACEUTICALS - SEES COMPLETION OF ENROLLMENT IN
PIVOTAL
STRIDE STUDY IN Q1 OF 2023; TOPLINE DATA IN Q4 OF 2023
    * RENEO PHARMACEUTICALS - UPDATE ON PLANS TO STUDY REN001 IN
PMM
PATIENTS WITH NDNA DEFECTS IN FIRST QUARTER OF 2023
    * Q3 EARNINGS PER SHARE VIEW $-0.57 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5vc7tC 
Further company coverage:  RPHM.O 
 ((reuters.briefs@thomsonreuters.com;))